Top Contract Development and Manufacturing Organizations In Europe
Nominate a Company
Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.
Top Contract Development and Manufacturing Organizations In Europe
CDMO News
European Biopharmaceutical CDMOs Add Capacity as Drug Developers Revisit Manufacturing Decisions
Wednesday, August 12, 2026
Moving a biopharmaceutical product from early development into commercial production involves more than finding available manufacturing space. Drug developers must decide whether a CDMO has the technical experience, production capabilities and process understanding needed to support a product as it moves through different stages. European CDMO manufacturers have become a larger part of this conversation as pharmaceutical companies continue to rely on external partners for biologics production. The growing complexity of biologic medicines has increased demand for facilities that can manage specialized processes while maintaining consistent quality requirements. Biologic
Pharmaceutical Companies Look Beyond Capacity When Choosing European CDMO Partners
Wednesday, August 12, 2026
A manufacturing delay can create setbacks that extend beyond the production timeline. For companies developing biologic medicines, problems during technology transfer or unexpected process issues can affect clinical supply schedules and add pressure to development budgets. These concerns are changing how pharmaceutical companies evaluate external manufacturing partners. European CDMOs are increasingly being judged on more than their ability to produce drug material. Pharmaceutical companies are looking closely at how these manufacturers support development activities, communicate technical information and handle the complexity of biologics production. Capacity and prod
European CDMOs Prepare for More Specialized Biopharmaceutical Manufacturing Demands
Wednesday, August 12, 2026
Manufacturing a modern biologic product often involves processes that require specialized knowledge and tightly controlled production environments. As drug developers move toward more complex therapies, European CDMO manufacturers are facing growing expectations around process expertise and specialized manufacturing support. The challenge for CDMOs is not simply producing larger volumes. Many newer therapies require manufacturing approaches that differ from established biologics production methods. This creates demand for facilities and teams that can manage complex development requirements from early stages through commercial manufacturing. Biopharmaceutical manufactu
CDMO Trends Leading to Industry Growth
Friday, January 13, 2023
With rising levels of growth and innovation, CDMO is witnessing new trends that businesses should pay attention to overcome the obstacles to progress. FREMONT, CA:The last two years have been especially significant for the biopharmaceutical industry, resulting in significant growth. There is a radical innovation scale ranging from the race to develop COVID-19 vaccines to discoveries in novel biologics treatments and more. However, there have been many challenges standing in the way of this progress, from supply chain disruption to a lack of specialist capabilities to get niche treatments to market. Despite these obstacles, CDMO trends are becom
CDMOs to Drive Innovation in the Pharmaceutical Industry
Friday, January 13, 2023
With changing customer demand, CDMOs are adjusting their business model and setting a clear course toward technology leadership, which will become an important factor in the coming years. FREMONT, CA:As flexible third-party service providers, CDMOs support pharmaceutical companies at every stage of the process of making medicines, such as by providing services in the research and development stages, providing support in manufacturing, and offering to formulate and finish processes. CDMOs have been rising in an increasingly dynamic mergers and acquisitions (M&A) landscape driven by consolidation. New developments are likely to continually cha
The Role of CDMOs in the Biopharmaceutical Ecosystem
Friday, January 13, 2023
CDMOs play a major role in the biopharmaceutical landscape by significantly contributing to a healthy life and providing continuous support to the industry in producing biopharmaceuticals for more diseases. FREMONT, CA:Biopharmaceutical industries have advanced significantly with the continuous development of novel biopharmaceuticals and the most sold drugs. Contract development and manufacturing organisations (CDMOs) have emerged as a result of the increased demand for biopharmaceuticals.. It is entrusted with the development and manufacturing of production processes for pharmaceutical companies. Biopharmaceutical drugs, or biologics, are drugs
